Elsevier

The Lancet

Volume 362, Issue 9398, 29 November 2003, Pages 1776-1777
The Lancet

Commentary
The rudimentary phase of personalised medicine: coronary risk scores

https://doi.org/10.1016/S0140-6736(03)14941-0Get rights and content

References (7)

  • MS Lauer et al.

    Cause of death in clinical research: time for reassessment?

    J Am Coll Cardiol

    (1999)
  • TA Pearson et al.

    AHA Guidelines for the primary prevention of cardiovascular disease and stroke: 2002 update. Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases

    Circulation

    (2002)
  • National Cholesterol Education Program. Risk assessment tool for estimating 10-year risk of developing hard CHD (myocardial infarction and coronary death)

There are more references available in the full text version of this article.

Cited by (33)

  • Predictors and moderators of response to internet-delivered Interpersonal Psychotherapy and Cognitive Behavior Therapy for depression

    2013, Journal of Affective Disorders
    Citation Excerpt :

    By identifying which characteristics of an individual predict the outcome of a specific treatment, a better match of treatment to the individual characteristics is achievable (Cuijpers et al., 2012; Simon and Perlis, 2010). Hence, this might contribute considerably to improvement of available treatments (Hamburg and Collins, 2010; Katsanis et al., 2008; Topol and Lauer, 2003). Knowledge about predictors and moderators of treatment outcome improves clinical decision about treatment (Andersson et al., 2008; MacKinnon, 2012), which has flow on effects to lower costs, reduce time in therapy, and enhance implementation and dissemination of depression treatment in the community.

  • 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults

    2010, Journal of the American College of Cardiology
    Citation Excerpt :

    A European “SCORE” (Systematic Coronary Risk Evaluation) was developed based on a regression model derived from observations of >200,000 adults (37). This model differs from the Framingham model in a variety of factors, including incorporation of age into a time scale and consideration of geographic variability within European countries as the calibration metric (35). Many of the multivariable coronary risk assessment functions have been evaluated for predictive capability (38).

  • Cost-Effective Prevention of Coronary Heart Disease

    2010, Journal for Nurse Practitioners
    Citation Excerpt :

    Finally, one or more risk factors in the setting of aging may predispose susceptible individuals to developing atherosclerosis and thus CHD. Overall, the goal in CHD prevention is to produce the largest relative risk reduction, the smallest number needed to treat (NNTT), and the lowest cost per quality-adjusted life year (QALY; a unit commonly used to measure heath gain or health effects where the duration of the survival is adjusted by the patient's quality of life) saved through accurate risk assessment and treatment via medication management and lifestyle modifications.9 Risk assessment tools can stratify CHD risk for individuals and identify the level of prevention that ultimately guides treatment strategies.

View all citing articles on Scopus
View full text